AI in Medicine News — 2026-10-13 (Tue) Evening News

Overview

Items touched diagnostics and imaging, hospital operations (AI note-taking), drug discovery deals and state-level AI regulation. Most diagnostic items are reports without clear clinical evidence, and the one with a stated caveat says clinical benefit remains uncertain (Los Angeles Business Journal).

Diagnosis and imaging

- A mammography item says AI may help identify breast cancers missed by mammograms, but clinical benefit remains uncertain. Detection figures and study type are not given in the headline (Los Angeles Business Journal). - An AI model that generates fake chest X-rays is reported to boost disease diagnosis "to Near Perfection". The headline gives no metric, dataset or validation stage (Bioengineer.org). - An AI model improves accuracy of cardiac ultrasound diagnoses. No figures or evidence stage are given (Medical Economics). - AI cuts diagnosis for eye disease from 23 days to 30 seconds. The headline does not say how this was measured or at what evidence stage (The Telegraph). - A market report covers AI in breast imaging for 2026-2033 (Grand View Research).

Clinical decision support

- California moves to ensure doctors aren't bound by AI, in a bills-and-laws item. Whether the measure has been enacted is not stated (Chief Healthcare Executive). - SCCM speakers said AI tools require strong governance and rigorous vetting (Specialty Pharmacy Continuum). - An item on high-reliability organizations looks at what they show us in the AI era (Inc.). - A market report says the AI healthcare command platform market will reach USD 6.20 Billion (openPR.com). 【Generative AI and medical documentation】 - JD Health showcased an "AI + Medical-Test-Diagnosis-Drug" closed loop at the Beijing Aging Expo, with nurse home visits as fast as 1 hour (BigGo Finance). - An AI tool may aid clinicians sorting seizure cases. The evidence stage is not stated (streamlinefeed.co.ke). 【Hospital operations and care delivery】 - Stonewall Jackson and Broaddus hospitals received funding for AI note-taking and telehealth (My Buckhannon). - Nelson Advisors says TORTUS Health's rollout in California is a significant test of whether generative AI can support direct clinical care delivery (healthcare.digital). - An item covers the cost of getting AI security wrong in the UK in 2026 (Appinventiv). - An item asks about the human cost of AI readiness in India's AI boom (Deccan Herald). - An investment firm acquired the AI platform Blackford Analysis from Bayer (Radiology Business). 【Drug discovery and clinical trials】 The headlines do not state a development stage (preclinical, Phase I and so on) for any item. - Chai Discovery landed a GSK deal after successful AI binder tests (AllSci). - Enveda Biosciences raised a $311 Million Series E for AI-powered drug discovery (Vocal). - Carterra and AstraZeneca are collaborating on AI-driven drug discovery (Manufacturing Chemist). - Feng Ren of Insilico Medicine said AI drug discovery must deliver repeatable value beyond hype (BioSpectrum Asia). - A market commentary says healthcare, biotech and pharma gain appeal as AI reshapes the economy (tokenpost.com). 【Medical device approval and regulation】 The only item is a legal commentary, not an approval, designation or guidance. It says AI-enabled medical devices require an integrated FDA and IP strategy. No product is named (JD Supra).

Safety, errors and bias

- A new state framework puts AI in healthcare in focus. The state is not named in the headline (Davis Journal). - Children are left out of medical AI, and a new method could help close the gap (Newswise). - An expert demands urgent safeguards for child AI apps (The Courier Mail). - Google's medical AI gets its first real-world test, with promising diagnoses, but the item asks whether it is safe without a doctor watching (TrialSite News). - An item asks whether AI can help healthcare move from treatment to prevention (Newswav). 【Research findings (major journals)】 - A Lancet report warns that AI and nuclear war pose the greatest long-term threats to humanity (cbs19.tv). A related item lists AI, nuclear war and bioweapons as possibly triggering the end of humanity by 2100 (NDTV). Neither headline is about clinical medicine.

Developments in Japan

- GENSHI AI's booth at Medical Japan Tokyo drew more than 500 visitors in total, with interest in MedLocal, a fully offline medical AI (PR TIMES). - Wolters Kluwer began offering UpToDate Expert AI, a generative AI for medicine, in Japan (Infoseek). - Kaunet added AI features to its consumables purchasing optimization diagnostic tool Supnavi. This is a purchasing tool, not a clinical one (EC no Mikata). - AI Security Lab and Heartbeats are co-hosting a seminar on October 15 about the SCS evaluation scheme that starts at the end of fiscal 2026. The headline concerns security diagnosis, not medicine (ScanNetSecurity). - The JD Health closed-loop item above also appeared in Japanese (BigGo Finance).

Statements by key figures

No tracked figures were listed. Named remarks in the material: - Feng Ren of Insilico Medicine said AI drug discovery must deliver repeatable value beyond hype (BioSpectrum Asia). - Shanmugam, whose title is not given in the headline, said the government is seeking co-operation with frontier AI firms on transparency and early warning when threats occur. The item is not specific to medicine (AsiaOne).